Proposed NIH Grant Review and Funding Revisions Spark Widespread Concern Among Researchers and Advocates

Proposed changes to the National Institutes of Health (NIH) grant review and funding processes, spearheaded by the Office of Management and Budget (OMB), are generating significant concern among leading researchers and patient advocates. These revisions, outlined in a recent OMB proposal, threaten to politicize scientific inquiry, undermine decades of established research practices, and potentially stifle crucial advancements in medicine and public health, particularly in fields like geriatrics and palliative care.

Background: The Pillars of NIH Funding

For decades, the NIH has served as the primary engine for biomedical research funding in the United States. Its mission, to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to extend healthy life and lessen the burden of illness and disability, has been guided by principles of scientific merit, peer review, and the pursuit of knowledge for the public good. The process typically involves rigorous peer review by panels of independent experts who evaluate the scientific quality, innovation, and potential impact of grant proposals. Funding decisions are then made based on these scientific assessments, with input from NIH scientific staff.

This established framework has been credited with numerous breakthroughs, from the development of life-saving vaccines and treatments for chronic diseases to a deeper understanding of aging and end-of-life care. However, recent proposals from the OMB suggest a significant departure from these foundational principles.

Key Proposed Revisions and Their Implications

The OMB’s proposed changes introduce several critical shifts that have alarmed the scientific community:

• Alignment with Executive Branch Policy: A core tenet of the proposed revisions is that grants must align with the policy priorities of the current executive administration. This marks a significant departure from the principle of funding the best available science, regardless of its immediate political alignment.
• Political Appointee Review: The proposal suggests that scientific review and approval of grants could ultimately be subject to the judgment of political appointees. This raises serious concerns about the potential for bias and the introduction of non-scientific considerations into funding decisions.
• Restrictions on Research Areas: The revisions reportedly include prohibitions against research focused on marginalized populations, disparities, and inequities in healthcare. This could severely limit studies addressing critical public health issues affecting vulnerable groups.
• Prohibition of International Collaboration: The proposed rules aim to restrict international collaboration, a vital component of many research endeavors, particularly in fields like dementia research where large datasets and diverse populations are essential.
• Limitations on Dissemination of Findings: Perhaps most concerning for researchers, the proposals suggest restrictions on presenting data at conferences and even on the types of journals in which findings can be published. This could lead to a chilling effect on scientific communication and the free exchange of ideas.
• Grant Cancellation and Ethical Concerns: A particularly alarming aspect is the potential to cancel grants mid-project if they no longer align with the institution’s or administration’s priorities. This raises significant ethical questions regarding the treatment of research participants who contribute their time and data with the expectation that their contributions will lead to meaningful outcomes.
• Impact on Training and Career Development: Simultaneously, there are proposals to cut down on training grants, which are crucial for nurturing the next generation of scientists. Coupled with potential limits on the number of grants a principal investigator can hold, these changes could lead to a significant reduction in the research workforce.

Expert Reactions: A United Front of Concern

Leading figures in geriatrics and palliative care have voiced strong opposition to these proposed changes, emphasizing their potential to undermine the very fabric of scientific progress.

Dr. Sean Morrison, Chair of the Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai, articulated the core concern: "The Office of Management and Budget has proposed a number of changes in how grants are funded. First of all, grants need to match the policy of the executive government. The second is that traditionally it’s been the best science that’s been put forward for funding and that comes through review panels. Now that science is approved by a political appointee or it is proposed that it would be approved by a political appointee, there are significant restrictions on the type of research that can be funded."

Dr. Stacy Fischer, a geriatrician and palliative care researcher at the University of Colorado, highlighted the ethical implications: "If a clinical trial is stopped midway because it no longer aligns with the institution’s priorities, that gift of their information, of their time that may be precious and limited is gone. It is wasted. It is, I think, really unethical and immoral to do that to people who have signed a consent as part of a clinical trial, expecting that their sacrifices and their gifts will not go to change practice or to help us understand something meaningful."

Dr. Ken Covinsky, a researcher at UCSF Division of Geriatrics, underscored the fundamental shift away from public trust: "The research enterprise, medical research, is a public trust. It exists to help our patients live better, free them of the burdens of disease. And so medical research exists for the needs of the public, for the needs of patients and their families. So now what this is saying is that after a medical research project has been vetted based on its impact on patients and families, a politician should decide if the medical research suits the interests of the current politicians in power."

Specific Areas of Contention

Several specific aspects of the proposed revisions have drawn particular ire:

The Erosion of Peer Review

The proposed shift towards political appointee review directly challenges the cornerstone of scientific funding: peer review. Stacy Fischer explained, "I think if I had to pick one thing, it’s that peer review just is no longer binding. I think that is the most important thing, that political point." She elaborated that the established process relies on the expertise of fellow scientists to identify strengths and weaknesses in research proposals, ensuring that funding is directed towards impactful science. Allowing political appointees to override these recommendations introduces a subjective and potentially biased element into a process that has historically prioritized scientific merit.

Restrictions on Research Topics and International Collaboration

The potential ban on research focused on marginalized populations, disparities, and inequities is seen as a grave threat to public health. Alex Smith noted, "But another thing we haven’t talked about as much are this, like, sort of ban on DEI and gender research. And this is, this is a huge issue… the complete ban is a terrible idea. Yes, sure, some things could have been done differently and probably should be done differently, but complete ban on research just erases and silences whole areas and whole populations."

Similarly, the prohibition on international collaboration was highlighted by Sean Morrison. "So much of the advances that we’ve seen in palliative care, for example, have come from work from Europe who are doing this type of work and focusing on it long before we were. And if we didn’t have the opportunity to be able to collaborate with those colleagues, take their models and see if they worked in the United States, for example, our field would be so far behind…" Ken Covinsky added a stark example: "if we don’t want Ebola to come to the shores of our country, it is sure as hell a good idea to collaborate with scientists in the regions where this virus currently exists."

The Challenge to Scientific Communication

The proposed restrictions on disseminating research findings, including limitations on conference presentations and journal publications, are viewed as a form of censorship. Sean Morrison stated, "In order for me to come on GeriPal and talk about my research, I would need to get approval from a political appointee at NIH because I’m talking about research that NIH funded… I can’t come on your show if this goes through without seeking permission." Stacy Fischer concurred, "It’s not really almost like censorship. It is de facto censorship."

The Publication Fee Conundrum

A recent development, also tied to OMB proposals, involves the stipulation that NIH grants cannot be used to pay for open-access publication fees. Stacy Fischer explained the dilemma: "And we can argue there’s good reason to say that this should be that these kind of results that the taxpayers have put in should be available to everyone. In this most recent OMB proposal, they’ve also said, well, your grant can’t pay for it. So the journals are saying, if you want us to make it open access immediately, you have to pay. And the NIH is saying, well, you can’t use a grant to pay for it. So that leaves a real problem." This creates a significant hurdle for researchers, particularly early-career scientists, who may struggle to afford these fees, thus hindering the timely dissemination of valuable research.

The Call to Action: Engaging in the Public Comment Period

With a critical public comment period open until mid-July, researchers and advocates are urging the public to voice their concerns. Stacy Fischer emphasized, "We are in an open comment period, and so we have until mid July… We need to show not only the OMB, but we need to show all of our Congress that we care about this and we care about protecting the lives of our patients."

Personalized comments are strongly encouraged. Sean Morrison advised, "It’s really important to personalize it. Talk about the patients you care for, talk about how science has helped you care for them and make it personal. Tell them why it affects you and how it’s going to affect your patients." Ken Covinsky added, "Our listeners should make it clear that they want scientific and medical research to improve their health and of the ones they love and that they don’t want the focus of research on addressing the political needs of politicians."

The broader implication is that these proposed changes extend beyond the NIH, potentially impacting all federal grant funding. The overarching message from the experts is clear: the integrity of scientific research, and consequently the future of healthcare advancements, hinges on maintaining an independent, merit-based funding system free from undue political influence. As the song popularized by Bob Dylan, chosen for this podcast, suggests, "The times they are a-changin’," but the hope is that these changes will lead to progress, not regression, in the pursuit of scientific knowledge for the betterment of all.